COST-EFFECTIVENESS OF VARIOUS COMBINATIONS OF HUMAN PAPILLOMAVIRUS (HPV)-BASED TESTING, INCLUDING GENOTYPING FOR HPV 16/18, FOR CERVICAL CANCER SCREENING

被引:2
|
作者
Huh, W. [1 ]
Williams, E. [2 ]
Bramley, T. [2 ]
Huang, J. [3 ]
Poulios, N. [3 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Xcenda, Palm Harbor, FL USA
[3] Roche Mol Diagnost, Pleasanton, CA USA
关键词
D O I
10.1016/j.jval.2013.03.699
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A142 / A143
页数:2
相关论文
共 50 条
  • [31] Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
    van Rosmalen, J.
    de Kok, I. M. C. M.
    van Ballegooijen, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (06) : 699 - 709
  • [32] The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples
    Song, Fangbin
    Du, Hui
    Wang, Chun
    Huang, Xia
    Wu, Ruifang
    PLOS ONE, 2020, 15 (06):
  • [33] Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening
    Chatzistamatiou, Kimon
    Moysiadis, Theodoros
    Moschaki, Viktoria
    Panteleris, Nikolaos
    Agorastos, Theodoros
    GYNECOLOGIC ONCOLOGY, 2016, 142 (01) : 120 - 127
  • [34] Maximising the cost-effectiveness of human papillomavirus testing for cervical screening in the context of routine HPV vaccination in Hong Kong: abridged secondary publication
    Leung, S. M. K.
    Wu, J.
    Chan, K. K. L.
    Jit, M.
    HONG KONG MEDICAL JOURNAL, 2023, 29 (04) : 11 - 15
  • [35] Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening
    Bidus, Michael A.
    Maxwell, G. Larry
    Kulasingam, Shalini
    Rose, G. Scott
    Elkas, John C.
    Chernofsky, Mildred
    Myers, Evan R.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (05): : 997 - 1005
  • [36] Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
    Arroyo Muehr, Laila Sara
    Gini, Andrea
    Yilmaz, Emel
    Hassan, Sadaf S.
    Lagheden, Camilla
    Hultin, Emilie
    Garcia Serrano, Ainhoa
    Ure, Agustin E.
    Andersson, Helena
    Merino, Roxana
    Elfstroem, K. Miriam
    Baussano, Iacopo
    Dillner, Joakim
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [37] Cost-effectiveness of primary HPV screening for cervical cancer in Germany - a decision analysis
    Sroczynski, G.
    Schnell-Inderst, P.
    Muehlberger, N.
    Lang, K.
    Aidelsburger, P.
    Wasem, J.
    Mittendorf, T.
    Engel, J.
    Hillemanns, P.
    Petry, K. U.
    Kraemer, A.
    Siebert, U.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (11) : 1633 - 1646
  • [38] COST-EFFECTIVENESS ANALYSIS FOR CERVICAL CANCER SCREENING USING HPV TESTS IN BRAZIL
    Franco Figueira, S.
    Cachoeira, C., V
    Petty Hasegawa, A. G.
    Kano, B. Y.
    Souza, F. H.
    Poulios, N.
    VALUE IN HEALTH, 2015, 18 (07) : A811 - A811
  • [39] COST-EFFECTIVENESS ANALYSIS FOR CERVICAL CANCER SCREENING USING HPV TESTS IN CHILE
    Figueira, Franco S.
    Cachoeira, C., V
    Souza, F. H.
    Kano, B. Y.
    Silva, M.
    Poulios, N.
    VALUE IN HEALTH, 2015, 18 (07) : A805 - A806
  • [40] Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis
    Naber, Steffie K.
    Matthijsse, Suzette M.
    Rozemeijer, Kirsten
    Penning, Corine
    de Kok, Inge M. C. M.
    van Ballegooijen, Marjolein
    PLOS ONE, 2016, 11 (01):